Hernández-Verdin, Isaias http://orcid.org/0000-0001-6295-2507
Akdemir, Kadir C.
Ramazzotti, Daniele
Caravagna, Giulio
Labreche, Karim
Mokhtari, Karima
Hoang-Xuan, Khê
Peyre, Matthieu
Bielle, Franck
Touat, Mehdi
Idbaih, Ahmed
Duval, Alex
Sanson, Marc
Alentorn, Agustí http://orcid.org/0000-0002-7220-2686
Funding for this research was provided by:
Institut National Du Cancer (SiRIC CURAMUS, SIRIC CURAMUS, SIRIC CURAMUS, SIRIC CURAMUS, SIRIC CURAMUS, SIRIC CURAMUS)
ARTC foundation
Bicocca 2020 Starting Grant and by a Premio Giovani Talenti dell'Università degli Studi di Milano-Bicocca
Agence Nationale de la Recherche (ANR-10-IAIHU-06)
Article History
Received: 26 May 2022
Accepted: 2 November 2022
First Online: 1 December 2022
Competing interests
: A.I. reports grants and travel funding from Carthera, research grants from Transgene/ Sanofi/Air Liquide/Nutritheragène, advisory board personal fees from Novocure/LeoPharma, outside the submitted work. F.B. reports interests out of the scope of this article: (i) a next-of-kin employed by Bristol Myers Squibb, (ii) funding of research by Abbvie, (iii) fees of travel and conference funded by Bristol Myers Squibb. The remaining authors declare no competing interests.